https://www.selleckchem.com/pr....oducts/mevastatin.ht
Five (14%) patients underwent a successful second Fontan. Freedom from death/transplant after Fontan takedown was 59%, 56%, and 52% at 1, 5, and 10years, respectively. The incidence of Fontan takedown is low, but mortality is high. The majority of takedowns occurred within 6months. Mortality was lowest when takedown occurred 2days and highest between 3weeks and 6months. A second Fontan is possible in a small proportion of survivors. The incidence of Fontan takedown is low, but mortality is high. The majority of takedowns occurred